Ad is loading...
LSRCX
Price
$3.68
Change
-$0.03 (-0.81%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

LSRCX vs VISVX

Header iconLSRCX vs VISVX Comparison
Open Charts LSRCX vs VISVXBanner chart's image
Lord Abbett Small Cap Value C
Price$3.68
Change-$0.03 (-0.81%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
LSRCX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LSRCX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSRCX is a StrongBuy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. LSRCX (422M). VISVX pays higher dividends than LSRCX: VISVX (1.90) vs LSRCX (0.66). LSRCX was incepted earlier than VISVX: LSRCX (28 years) vs VISVX (27 years). LSRCX is a more actively managed with annual turnover of: 34.00 vs. VISVX (16.00). LSRCX has a lower initial minimum investment than VISVX: LSRCX (1000) vs VISVX (3000). LSRCX annual gain was more profitable for investors over the last year : 30.96 vs. VISVX (28.71). VISVX return over 5 years is better than : 57.32 vs. LSRCX (-54.84).
LSRCXVISVXLSRCX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years27 years-
Gain YTD16.82515.433109%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets422M57.6B1%
Annual Yield % from dividends0.661.9035%
Returns for 1 year30.9628.71108%
Returns for 3 years-45.5613.23-344%
Returns for 5 years-54.8457.32-96%
Returns for 10 years-86.28108.21-80%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics